Literature DB >> 12657978

Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness.

Mitchell P Fink1.   

Abstract

PURPOSE OF REVIEW: Tight junctions between adjacent epithelial cells are essential for the maintenance of compositionally distinct fluid compartments in various organs, such as the liver, lungs, kidneys, and intestine. These epithelial organs are commonly affected in the condition known as multiple organ dysfunction syndrome, which can complicate the clinical course of patients with sepsis or other conditions associated with poorly controlled systemic inflammation. The gut serves as a useful model for this problem, and studies using reductionist in vitro models and experiments carried out using laboratory animals are starting to clarify the cellular and biochemical mechanisms that are responsible for intestinal epithelial hyperpermeability secondary to critical illness. RECENT
FINDINGS: One key factor that has been identified is excessive production of nitric oxide and related species, although other factors, such as increased expression of the cytokine interleukin 6, appear to be important as well. A newly described, cytokine-like molecule, high-mobility group B1, increases permeability of cultured epithelial monolayers in vitro and murine ileal mucosa in vivo.
SUMMARY: Epithelial dysfunction may be a common final pathway contributing to organ dysfunction in sepsis and other forms of critical illness. Copyright 2003 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657978     DOI: 10.1097/00075198-200304000-00011

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  65 in total

1.  Nutritional stimulation of the autonomic nervous system.

Authors:  Misha D P Luyer; Quirine Habes; Richard van Hak; Wim Buurman
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

Review 2.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Microbiome as mediator: Do systemic infections start in the gut?

Authors:  Melissa Latorre; Suneeta Krishnareddy; Daniel E Freedberg
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 4.  Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness.

Authors:  Jessica A Clark; Craig M Coopersmith
Journal:  Shock       Date:  2007-10       Impact factor: 3.454

5.  Oxidative stress-induced disruption of epithelial and endothelial tight junctions.

Authors:  Radhakrishna Rao
Journal:  Front Biosci       Date:  2008-05-01

6.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

Review 7.  [Intestinal malperfusion in critical care patients].

Authors:  G Knichwitz; C Kruse; H van Aken
Journal:  Anaesthesist       Date:  2005-01       Impact factor: 1.041

Review 8.  Resuscitation-induced intestinal edema and related dysfunction: state of the science.

Authors:  Shinil K Shah; Karen S Uray; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  J Surg Res       Date:  2009-09-29       Impact factor: 2.192

9.  Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.

Authors:  Erika Rendón-Huerta; Fortoul Teresa; Gorráez María Teresa; Garcia-Samper Xochitl; Alvarez-Fernández Georgina; Zavala-Zendejas Veronica; Luis Felipe Montaño
Journal:  J Gastrointest Cancer       Date:  2009-12-04

10.  Epinephrine: is it really the black sheep of vasoactive agents?

Authors:  Ritwick Agrawal; Ali Al-Khafaji; Sachin Yende
Journal:  Crit Care       Date:  2010-05-13       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.